How do you view the balance between opting for percutaneous coronary intervention and prioritizing optimal medical therapy as the initial treatment choice for patients with stable angina?  

This is the holy grail of Cardiovascular practice on how to marry the prevalent scientific data to clinical practice. In my opinion, an astute history and in-depth analysis of patient symptoms (angina and ischemia with their varied clinical presentations) hold the key to individualized patient care...

GDMT is always the primary focus in stable patients, and titration of therapy to maximally tolerated doses is ideal. In patients with good functional capacity with any reduction in their functional capacity related to symptoms that persist despite initiation and up-titration of GDMT, proceeding with...

High doses of beta blockers calcium channel blockers and nitrates for lifetime use expose patients to potential medical side effects of these medicines. The age of the patient should also be considered. It is critical in making a decision about revascularization. Active patients below the age of 65 ...